Synthesis and radiopharmacological evaluation of 2´-(4-fluorophenyl)-21-[18F]fluoro-20-oxo-11β,17α-dihydroxy-pregn-4-eno[3,2-c]pyrazole as potential glucocorticoid receptor ligand for positron emission tomography (PET)


Synthesis and radiopharmacological evaluation of 2´-(4-fluorophenyl)-21-[18F]fluoro-20-oxo-11β,17α-dihydroxy-pregn-4-eno[3,2-c]pyrazole as potential glucocorticoid receptor ligand for positron emission tomography (PET)

Wüst, F.; Knieß, T.; Kretzschmar, M.; Bergmann, R.

The radiosynthesis and the radiopharmacological evaluation of pyrazolo steroid 2´-(4-fluorophenyl)-21-[18F]fluoro-20-oxo-11β,17α-dihydroxy-pregn-4-eno[3,2-c]pyrazole [18F]-2 is described. The radiolabeling was accomplished in 3 - 4 % decay-corrected radiochemical yield within 80 min at an specific radioactivity of 0.8-1.2 Ci/μmol. Biodistribution studies in male Wistar rats showed an initial brain uptake of 0.25 ± 0.03 % ID/g after 5 min, which remained constant over 60 min. The radiopharmacological evaluation of compound [18F]-2 was completed with autoradiography using rat brain sections and micro-PET imaging.

Keywords: Positron emission tomography; Glucocorticoid receptor; Radiolabeling

  • Bioorganic & Medicinal Chemistry Letters 15(2005), 1303-1306

Permalink: https://www.hzdr.de/publications/Publ-7204
Publ.-Id: 7204